{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T03:13:39Z","timestamp":1774840419797,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1997,4,1]],"date-time":"1997-04-01T00:00:00Z","timestamp":859852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[1997,4]]},"DOI":"10.1016\/s0014-2999(97)00101-5","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T15:15:26Z","timestamp":1027610126000},"page":"13-20","source":"Crossref","is-referenced-by-count":72,"title":["Regional variation in the effects of nicotine on catecholamine overflow in rat brain"],"prefix":"10.1016","volume":"325","author":[{"given":"Maureen E.M","family":"Benwell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.K","family":"Balfour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0014-2999(97)00101-5_BIB1","doi-asserted-by":"crossref","unstructured":"Abercrombie, E.D., K.A. Keefe, D.S. Di Frischia and M.J. Zigmond, 1989, Differential effects of stress on in vivo dopamine release in the striatum, nucleus accumbens and medial prefrontal cortex, J. Neurochem. 52, 1655.","DOI":"10.1111\/j.1471-4159.1989.tb09224.x"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB2","doi-asserted-by":"crossref","unstructured":"Benowitz, N.L., H. Porchet and P. Jacob III, 1990, Pharmacokinetics, metabolism and pharmacodynamics of nicotine, in: Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects, eds. S. Wonnacott, M.A.H. Russell and I.P. Stolerman (Oxford University Press, Oxford) p. 112.","DOI":"10.1093\/oso\/9780192616142.003.0004"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB3","doi-asserted-by":"crossref","unstructured":"Benwell, M.E.M. and D.J.K. Balfour, 1992, The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine, and locomotor activity, Br. J. Pharmacol. 105, 849.","DOI":"10.1111\/j.1476-5381.1992.tb09067.x"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB4","doi-asserted-by":"crossref","unstructured":"Benwell, M.E.M., D.J.K. Balfour and J.M. Anderson, 1988, Evidence that smoking increases the density of nicotine binding sites in human brain, J. Neurochem. 50, 1243.","DOI":"10.1111\/j.1471-4159.1988.tb10600.x"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB5","doi-asserted-by":"crossref","unstructured":"Benwell, M.E.M., D.J.K. Balfour and H.M. Lucchi, 1993, Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine, Psychopharmacology 112, 467.","DOI":"10.1007\/BF02244896"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB6","doi-asserted-by":"crossref","unstructured":"Benwell, M.E.M., D.J.K. Balfour and C.E. Birrell, 1995, Desensitisation of nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine, Br. J. Pharmacol. 114, 454.","DOI":"10.1111\/j.1476-5381.1995.tb13248.x"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB7","unstructured":"Birrell, C.E. and D.J.K. Balfour, 1995, Studies on the mechanisms underlying sensitisation of the mesoaccumbens dopamine response to nicotine in the rat, Br. J. Pharmacol. 116, 337 pp."},{"key":"10.1016\/S0014-2999(97)00101-5_BIB8","doi-asserted-by":"crossref","unstructured":"Brazell, M.P., S.N. Mitchell, M.H. Joseph and J.A. Gray, 1990, Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4,dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with Caudate-Putamen, Neuropharmacology 29, 1177.","DOI":"10.1016\/0028-3908(90)90042-P"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB9","doi-asserted-by":"crossref","unstructured":"Clarke, P.B.S., 1990, Dopaminergic mechanisms in the locomotor stimulant effects of nicotine, Biochem. Pharmacol. 40, 1427.","DOI":"10.1016\/0006-2952(90)90436-O"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB10","doi-asserted-by":"crossref","unstructured":"Clarke, P.B.S. and A. Pert, 1985, Autoradiographic evidence for nicotinic receptors on nigrostriatal and mesolimbic dopaminergic neurones, Brain Res. 348, 355.","DOI":"10.1016\/0006-8993(85)90456-1"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB11","unstructured":"Clarke, P.B.S., D.S. Fu, A. Jakubovic and H.C. Fibiger, 1988, Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant actions of nicotine in rats, J. Pharmacol. Exp. Ther. 246, 701."},{"key":"10.1016\/S0014-2999(97)00101-5_BIB12","doi-asserted-by":"crossref","unstructured":"Corrigall, W.A and K.M. Coen, 1991, Selective dopamine antagonist reduce nicotine self-administration, Psychopharmacology 104, 171.","DOI":"10.1007\/BF02244174"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB13","doi-asserted-by":"crossref","unstructured":"Corrigall, W.A, K.B.J. Franklin, K.M. Coen and P.B.S. Clarke, 1992, The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine, Psychopharmacology 107, 285.","DOI":"10.1007\/BF02245149"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB14","doi-asserted-by":"crossref","unstructured":"Corrigall, W.A., K.M. Coen and K.L. Adamson, 1994, Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area, Brain Res. 653, 278.","DOI":"10.1016\/0006-8993(94)90401-4"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB15","doi-asserted-by":"crossref","unstructured":"Di Chiara, G. and A. Imperato, 1988, Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats, Proc. Natl. Acad. Sci. USA 85, 5274.","DOI":"10.1073\/pnas.85.14.5274"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB16","doi-asserted-by":"crossref","unstructured":"Garris, P.A. and R.M. Wightman, 1994, Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex and striatum: an in vivo voltammetric study, J. Neurosci. 14, 442.","DOI":"10.1523\/JNEUROSCI.14-01-00442.1994"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB17","doi-asserted-by":"crossref","unstructured":"Giorgieff-Chesselet, M.F., M.L. Kemel, D. Wanscheer and J. Glowinski, 1979, Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: effects of nicotine in a low concentration, Life Sci. 25, 1257.","DOI":"10.1016\/0024-3205(79)90469-7"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB18","doi-asserted-by":"crossref","unstructured":"Grenhoff, J. and T.H. Svensson, 1988, Selective stimulation of limbic dopamine activity by nicotine, Acta Physiol. Scand. 133, 595.","DOI":"10.1111\/j.1748-1716.1988.tb08450.x"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB19","doi-asserted-by":"crossref","unstructured":"Imperato, A., A. Mulas and G. Di Chiara, 1986, Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats, Eur. J. Pharmacol. 132, 337.","DOI":"10.1016\/0014-2999(86)90629-1"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB20","doi-asserted-by":"crossref","unstructured":"Marks, M.J. and A.C. Collins, 1985, Tolerance, cross-tolerance and receptors after chronic nicotine or oxotremorine, Pharmacol. Biochem. Behav. 22, 283.","DOI":"10.1016\/0091-3057(85)90392-2"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB21","unstructured":"Marks, M.J., J.B. Burch and A.C. Collins, 1983, Effects of chronic nicotine infusions on tolerance development and nicotinic receptors, J. Pharmacol. Exp. Ther. 226, 817."},{"key":"10.1016\/S0014-2999(97)00101-5_BIB22","doi-asserted-by":"crossref","unstructured":"Marshall, J.F., S.J. O'Dell, R. Navarrete and A.J. Rosenstein, 1990, Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum, Neuroscience 37, 11.","DOI":"10.1016\/0306-4522(90)90187-9"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB23","doi-asserted-by":"crossref","unstructured":"Mereu, G., K.-W.P. Yoon, V. Boi, G.L. Gessa, L. Neas and T.C. Westfall, 1987, Preferential stimulation of ventral tegmental area dopaminergic neurones by nicotine, Eur. J. Pharmacol. 141, 395.","DOI":"10.1016\/0014-2999(87)90556-5"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB24","doi-asserted-by":"crossref","unstructured":"Mitchell, S.N., 1993, Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine, Neuropharmacology 32, 937.","DOI":"10.1016\/0028-3908(93)90058-B"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB25","doi-asserted-by":"crossref","unstructured":"Nisell, M., G.G. Nomikos and T.H. Svensson, 1994, Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area, Synapse 16, 36.","DOI":"10.1002\/syn.890160105"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB26","unstructured":"Paxinos, G. and C. Watson, 1986, The Rat Brain in Stereotaxic Coordinates, 2nd edn. (Academic Press, Sydney)."},{"key":"10.1016\/S0014-2999(97)00101-5_BIB27","doi-asserted-by":"crossref","unstructured":"Rapier, C., G.G. Lunt and S. Wonnacott, 1988, Nicotinic modulation of dopamine release from striatal synaptosomes: pharmacological characterisation, J. Neurochem. 54, 937.","DOI":"10.1111\/j.1471-4159.1990.tb02341.x"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB28","doi-asserted-by":"crossref","unstructured":"Russell, M.A.H., 1990, Nicotine intake and its control over smoking, in: Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects, eds. S. Wonnacott, M.A.H. Russell and I.P. Stolerman (Oxford University Press, Oxford) p. 374.","DOI":"10.1093\/oso\/9780192616142.003.0011"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB29","doi-asserted-by":"crossref","unstructured":"Schwartz, R.D and K.J. Kellar, 1985, In vivo regulation of (3H)acetylcholine recognition sites in brain by nicotinic cholinergic drugs, J. Neurochem. 45, 427.","DOI":"10.1111\/j.1471-4159.1985.tb04005.x"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB30","doi-asserted-by":"crossref","unstructured":"Singer, G., M. Wallace and R. Hall, 1982, Effects of dopaminergic nucleus accumbens lesions on the acquisition of schedule induced self injection of nicotine in the rat, Pharmacol. Biochem. Behav. 17, 579.","DOI":"10.1016\/0091-3057(82)90321-5"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB31","doi-asserted-by":"crossref","unstructured":"Somjet, C.G., Allen, B.W., Balestrino, M. and Aitken, P. (1987) Patho-physiology of pH and calcium in blood stream and brain, Can. J. Physiol. Pharmacol. 65, 1078.","DOI":"10.1139\/y87-169"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB32","doi-asserted-by":"crossref","unstructured":"Vale, A.L. and D.J.K. Balfour, 1989, Aversive environmental stimuli as a factor in the psychostimulant response to nicotine, Pharmacol. Biochem. Behav. 32, 857.","DOI":"10.1016\/0091-3057(89)90048-8"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB33","doi-asserted-by":"crossref","unstructured":"Wada, E., K. Wada, J. Boulter, E. Deneris, S. Heinemann, J. Patrick and L.W. Swanson, 1989, Distribution of alpha2, alpha3, alpha4 and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridisation histochemical study in the rat, J. Comp. Neurol. 284, 314.","DOI":"10.1002\/cne.902840212"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB34","doi-asserted-by":"crossref","unstructured":"Westerink, B.H.C., Hofsteede, H.M., Damsma, G. and De Vries, J.B. (1988) The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis, Naunyn-Schmiedeberg's Arch. Pharmacol. 337, 373.","DOI":"10.1007\/BF00169526"},{"key":"10.1016\/S0014-2999(97)00101-5_BIB35","doi-asserted-by":"crossref","unstructured":"Wonnacott, S., 1990, Characterization of nicotine receptor sites in brain, in: Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects, eds. S. Wonnacott, M.A.H. Russell and I.P. Stolerman (Oxford University Press, Oxford) p. 226.","DOI":"10.1093\/oso\/9780192616142.003.0007"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299997001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299997001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T15:22:45Z","timestamp":1704036165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299997001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["S0014299997001015"],"URL":"https:\/\/doi.org\/10.1016\/s0014-2999(97)00101-5","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[1997,4]]}}}